Cite

HARVARD Citation

    Briand, C. et al. (2019). Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency. Annals of the rheumatic diseases. 78 (3), pp. 431-433. [Online]. 
  
Back to record